Inspire Investing LLC Grows Stock Position in Align Technology, Inc. $ALGN

Inspire Investing LLC increased its stake in Align Technology, Inc. (NASDAQ:ALGN) by 59.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,013 shares of the medical equipment provider’s stock after acquiring an additional 753 shares during the period. Inspire Investing LLC’s holdings in Align Technology were worth $320,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of Align Technology by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 8,441,592 shares of the medical equipment provider’s stock worth $1,341,031,000 after purchasing an additional 185,187 shares during the period. Ninety One UK Ltd increased its position in shares of Align Technology by 58.7% in the first quarter. Ninety One UK Ltd now owns 1,937,555 shares of the medical equipment provider’s stock worth $307,800,000 after acquiring an additional 716,954 shares in the last quarter. Invesco Ltd. raised its stake in shares of Align Technology by 12.7% in the 1st quarter. Invesco Ltd. now owns 1,219,715 shares of the medical equipment provider’s stock valued at $193,764,000 after acquiring an additional 137,553 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Align Technology by 32.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 832,313 shares of the medical equipment provider’s stock valued at $132,221,000 after acquiring an additional 202,616 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its position in Align Technology by 0.7% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 736,635 shares of the medical equipment provider’s stock worth $117,022,000 after purchasing an additional 4,789 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Align Technology Price Performance

Align Technology stock opened at $129.44 on Thursday. The stock has a market capitalization of $9.38 billion, a PE ratio of 21.83, a price-to-earnings-growth ratio of 1.49 and a beta of 1.65. The firm has a 50 day simple moving average of $156.67 and a 200-day simple moving average of $169.00. Align Technology, Inc. has a 12-month low of $127.70 and a 12-month high of $262.87.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter last year, the company posted $2.41 EPS. Align Technology’s revenue was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. On average, analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology declared that its Board of Directors has approved a stock buyback program on Tuesday, August 5th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the medical equipment provider to repurchase up to 2% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s leadership believes its stock is undervalued.

Insider Buying and Selling at Align Technology

In other news, CEO Joseph M. Hogan acquired 7,576 shares of the company’s stock in a transaction that occurred on Friday, August 1st. The shares were purchased at an average price of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the acquisition, the chief executive officer owned 184,945 shares of the company’s stock, valued at approximately $24,318,418.05. This represents a 4.27% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.66% of the stock is owned by company insiders.

Analysts Set New Price Targets

ALGN has been the subject of several recent research reports. Morgan Stanley reaffirmed an “equal weight” rating and issued a $154.00 price objective (down previously from $249.00) on shares of Align Technology in a research report on Thursday, July 31st. Evercore ISI raised their price target on shares of Align Technology from $200.00 to $220.00 and gave the company an “outperform” rating in a report on Wednesday, July 9th. Mizuho set a $210.00 price objective on shares of Align Technology in a report on Thursday, July 31st. Wells Fargo & Company lowered their target price on Align Technology from $246.00 to $199.00 and set an “overweight” rating for the company in a research note on Thursday, July 31st. Finally, Stifel Nicolaus cut their price target on Align Technology from $275.00 to $200.00 and set a “buy” rating on the stock in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Align Technology presently has an average rating of “Moderate Buy” and a consensus target price of $215.00.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.